Let's train the model together.
MDT Precision will soon open its closed beta to selected healthcare institutions and oncology specialists. Leave your details to join the beta program, become one of our pilot clinics, talk to us as an investor, or stay informed of updates.
- Free trial versionFull access to the platform throughout the pilot period.
- Direct product impactYour feedback shapes the roadmap and the model.
- Board-quality second opinionFast, evidence-based support on your cases.
Application form
Filling in the form takes about a minute.
What we ask of you
During the pilot period, try the platform on your own cases and share your experience through brief feedback.
How does it work?
- Submit your application
- Our team gets in touch with you
- Your access is activated
- You try it on your cases and share feedback
Frequently asked questions
Is the beta program paid?
No. Access to the platform is free throughout the pilot period.
Which test results does the platform work with?
It works with tissue- and liquid biopsy-based comprehensive genomic profiling (CGP) results.
Who can apply?
Oncology specialists, healthcare institutions that want to run a pilot, and investors.
How is my application data processed?
Your details are processed solely to contact you and run the beta program, under our Privacy Notice (KVKK).
Who makes the treatment decision?
The platform is a decision support tool. The final clinical decision always rests with the physician.